Expression Status of p16 Protein Is Associated with Human Papillomavirus Oncogenic Potential in Cervical and Genital Lesions
Authors:
- Takaaki SanoTSTakaaki Sano
- Tetsunari OyamaTOTetsunari Oyama
- Kenji KashiwabaraKKKenji Kashiwabara
- Toshio FukudaTFToshio Fukuda
- Takashi NakajimaTNTakashi Nakajima
- 1 December 1998
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 153 (6) , 1741-1748
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Correlation between methylation status of thep16/CDKN2 gene and the expression of p16 and Rb proteins in primary non-small cell lung cancersInternational Journal of Cancer, 1998
- Papillomavirus infections — a major cause of human cancersBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- CDKN2 in HPV‐positive and HPV‐negative cervical‐carcinoma cell linesInternational Journal of Cancer, 1995
- Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibitionNature, 1995
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Human Papillomavirus Infection of the CervixObstetrics & Gynecology, 1992
- Detection and Typing of Multiple Genital Human Papillomaviruses by DNA Amplification with Consensus PrimersJapanese Journal of Cancer Research, 1991
- Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: A novel mechanism for E1A trans-activationCell, 1990
- Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53Science, 1990
- The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1ACell, 1988